ATE138074T1 - Disulfat von ws-7622a, verfahren zur herstellung und benutzung - Google Patents

Disulfat von ws-7622a, verfahren zur herstellung und benutzung

Info

Publication number
ATE138074T1
ATE138074T1 AT91110243T AT91110243T ATE138074T1 AT E138074 T1 ATE138074 T1 AT E138074T1 AT 91110243 T AT91110243 T AT 91110243T AT 91110243 T AT91110243 T AT 91110243T AT E138074 T1 ATE138074 T1 AT E138074T1
Authority
AT
Austria
Prior art keywords
preparation
disulphate
ws7622a
ferm
sulfates
Prior art date
Application number
AT91110243T
Other languages
English (en)
Inventor
Shigehiro Takase
Hiroshi Hatanaka
Masami Ezaki
Eisaku Tsujii
Masanori Okamoto
Nobuharu Shigematsu
Masakuni Okuhara
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE138074T1 publication Critical patent/ATE138074T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
AT91110243T 1990-06-29 1991-06-21 Disulfat von ws-7622a, verfahren zur herstellung und benutzung ATE138074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
ATE138074T1 true ATE138074T1 (de) 1996-06-15

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91110243T ATE138074T1 (de) 1990-06-29 1991-06-21 Disulfat von ws-7622a, verfahren zur herstellung und benutzung

Country Status (22)

Country Link
US (2) US5292510A (de)
EP (1) EP0465895B1 (de)
JP (1) JP2663763B2 (de)
KR (1) KR100198693B1 (de)
CN (1) CN1073115C (de)
AT (1) ATE138074T1 (de)
AU (1) AU640241B2 (de)
CA (1) CA2045761C (de)
DE (1) DE69119488T2 (de)
DK (1) DK0465895T3 (de)
ES (1) ES2087178T3 (de)
FI (1) FI106554B (de)
GB (1) GB9014546D0 (de)
GR (1) GR3020184T3 (de)
HU (1) HU213398B (de)
IE (1) IE75702B1 (de)
IL (1) IL98394A (de)
NO (1) NO301643B1 (de)
PH (1) PH31239A (de)
PT (1) PT98134B (de)
RU (1) RU2087482C1 (de)
ZA (1) ZA914349B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0519354T3 (da) * 1991-06-18 1998-01-12 Fujisawa Pharmaceutical Co Profylaktisk/terapeutisk præparat indeholdende WS7622A til forebyggelse eller behandling af dissemineret intravaskulær koagulation, kronisk luftvejsinfektionssygdom eller kronisk bronkitis
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
ES2421505T3 (es) * 1998-02-24 2013-09-03 Astellas Pharma Inc Preventivos/remedios contra el envejecimiento de la piel
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心） 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
EP0465895A1 (de) 1992-01-15
IE75702B1 (en) 1997-09-10
ES2087178T3 (es) 1996-07-16
GB9014546D0 (en) 1990-08-22
HU912198D0 (en) 1991-12-30
NO912561L (no) 1991-12-30
FI912914A0 (fi) 1991-06-17
PT98134B (pt) 1998-12-31
NO301643B1 (no) 1997-11-24
US5292510A (en) 1994-03-08
HU213398B (en) 1997-06-30
IL98394A (en) 1995-03-30
DE69119488T2 (de) 1996-10-02
ZA914349B (en) 1992-03-25
CA2045761C (en) 1999-09-21
KR920000920A (ko) 1992-01-29
HUT58351A (en) 1992-02-28
JPH04279600A (ja) 1992-10-05
JP2663763B2 (ja) 1997-10-15
KR100198693B1 (ko) 1999-06-15
DK0465895T3 (da) 1996-06-03
CN1073115C (zh) 2001-10-17
FI912914L (fi) 1991-12-30
EP0465895B1 (de) 1996-05-15
CN1057655A (zh) 1992-01-08
DE69119488D1 (de) 1996-06-20
IL98394A0 (en) 1992-07-15
FI106554B (fi) 2001-02-28
PT98134A (pt) 1992-06-30
CA2045761A1 (en) 1991-12-30
RU2087482C1 (ru) 1997-08-20
GR3020184T3 (en) 1996-09-30
US5364624A (en) 1994-11-15
IE912047A1 (en) 1992-01-01
NO912561D0 (no) 1991-06-28
AU7939491A (en) 1992-01-09
AU640241B2 (en) 1993-08-19
PH31239A (en) 1998-06-18

Similar Documents

Publication Publication Date Title
HUT54144A (en) Process for producing 3-desmethylmevalonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DE69021176D1 (de) Polypeptid und Verfahren zu dessen Herstellung.
ES2115760T3 (es) Derivados de 4''-desoxieritromicina.
AU8912891A (en) Biologically active amines
FI891581A0 (fi) Peptidderivat.
TW252979B (de)
ATE138074T1 (de) Disulfat von ws-7622a, verfahren zur herstellung und benutzung
AU7125991A (en) Novel antiulcer substance
DE59106966D1 (de) Verfahren zur Herstellung von 3-Amino-2-(het)aroyl-acrylsäurederivaten.
DE69019848D1 (de) Substanzen WS 7622 A,B,C und D, deren Derivate, Verfahren zu deren Herstellung sowie deren Verwendung.
ES519605A0 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
DE69116423D1 (de) 3'-Deamino-4'-deoxy-4'-amino-8-fluoranthracycline und Verfahren zu ihrer Herstellung
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
DE68918071D1 (de) Antibiotikum A80915 und Verfahren zu seiner Herstellung.
ATE11669T1 (de) Vasodilator, verfahren zur herstellung und arzneimittelzusammensetzungen.
HUT49886A (en) Process for producing new beta-lactam antibiotics and pharmaceutical compositions comprising same
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
DE59304579D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-5-hydroxyoxindolen und deren Etherderivaten
DE59010385D1 (de) Polare Cephalosporinderivate und Verfahren zu ihrer Herstellung
GR3020922T3 (en) Amide derivatives of 1-amino-octahydropyrido[2,1-c][1,4]oxazine, processes for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee